| 1 | Dupilumab | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [5] 51 51, 97, 98, 160, 162 💬
|
| 2 | Dupilumab (blinded) | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 98 98 💬
|
| 3 | Dupilumab (open-label) | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 98 98 💬
|
| 4 | Dupilumab 300Mg Solution for Injection | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 51 51 💬
|
| 5 | Dupilumab Injection | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬
|
| 6 | Dupilumab Prefilled Syringe | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬
|